BRIEF

on Chowis

Chowis to Develop Customized Cosmetics Diagnostic Platform in Partnership With Kolmar Korea

Chowis Co. Ltd., a leading provider of AI skin diagnostic solutions in South Korea, has entered into a strategic partnership with Kolmar Korea to develop an advanced customized cosmetics diagnostic platform.

On May 29th, the collaboration was formalized through a Memorandum of Understanding (MOU) signed at Kolmar Korea's R&D Complex in Naegok-dong, Seocho-gu, Seoul. The signing ceremony was attended by Han Sang-geun, Vice President of Korea Kolmar's Technology Research Institute, and Ryan WS Choi, CEO of Chowis Co., Ltd.

Chowis Co., Ltd. is renowned for its mobile skin, hair, and scalp diagnostic solutions that leverage AI and LED optical technology. Their services include a web-based application that analyzes various skin conditions such as wrinkles, pigmentation, pores, and redness through full-face image captures.

The partnership aims to combine the technological expertise of both companies to develop a customized cosmetics diagnostic platform. Chowis Co., Ltd. will utilize its optical diagnostic technology to assess consumers' skin conditions, while Kolmar Korea will interpret these analyses to recommend the optimal products tailored to individual skin profiles.

The diagnostic process will allow consumers to capture images of their faces via a beauty company's website or app. The platform will analyze multiple skin conditions and incorporate a brief questionnaire about the consumers' usual skin concerns and lifestyle habits. Based on this information, it will recommend personalized cosmetics. Should consumers decide to purchase the suggested products, Kolmar Korea will manufacture them. This initiative aims to support beauty companies in entering the customized cosmetics market by providing them with the diagnostic platform.

R. E.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Chowis news